Skip to content

Effect Of Ayurveda Protocol In Hypertension

Efficacy Of Integrated Ayurveda Protocol In Essential Hypertension A Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072464
Enrollment
60
Registered
2024-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

Dr Bawadkar Prasad Ramesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Criteria for the selection of the patients will be based on the guidelines suggested by Joint National Committee. 2. Patients of stage 1 hypertension as per the 7th Joint National Committee guidelines. 3. Newly diagnosed cases of Essential Hypertension on 2 to 3 successive blood pressure measurements.

Exclusion criteria

Exclusion criteria: 1. The patients with Ischemic Heart Disease, Coronary Heart Disease, Coarctation of Aorta, Renal Failure or any Endocrine Diseases. 2. Hypertension with cerebral complications e.g. hypertensive encephalopathy, cerebral hemorrhage, convulsive seizure. 3. Patients of stage 2 hypertension as per the 7th Joint National Committee guidelines. 4. Malignant hypertension. 5. Pregnant and Lactating female patients.

Design outcomes

Primary

MeasureTime frame
1. Systolic Blood Pressure 2. Diastolic Blood Pressure Timepoint: Baseline, 15th Day, 30th Day, 45th Day and 60th Day.

Secondary

MeasureTime frame
1. Mean arterial pressure. 2. Pittsburgh Sleep Quality Index. 3. Depression Anxiety Stress Scale long form. Timepoint: Baseline, 15th Day, 30th Day, 45th Day and 60th Day.;Short Form 36 Quality of life.Timepoint: Baseline, 30th Day and 60th Day. ;Perceived Symptoms associated with antihypertensive drugs scaleTimepoint: 15th Day, 30th Day, 45th Day and 60th Day. ;Serum Creatinine.Timepoint: Baseline and 60th Day.

Countries

India

Contacts

Public ContactDr Suketha Kumari

KAHERs Shri BMK Ayurveda Mahavidyalaya Post Graduate Studies And Research Centre Shahapur Belagavi

sukethashetty411@gmail.com9483637757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026